CSIMarket



Worst Performing Stocks In Medical Equipment & Supplies Industry Over The Past 12 Months



 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 
 

Shares are down by -14.78% on average, in Medical Equipment & Supplies Industry over the past 12 months.

Here are the Worst performing stocks in Medical Equipment & Supplies Industry.




INBS

$1.53

$-332.5500 -99.54%
Last 12 Months


INBS

$1.53

$-332.5500 -99.54%



Intelligent Bio Solutions Inc

Intelligent Bio Solutions Inc stock dropped -99.54% over the past 12 months.


Intelligent Bio Solutions Inc*s business model focuses on providing intelligent solutions in the bio industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.182 mill. $ 2.516 mill. $ -10.067 mill. 2 mill. - Y/Y 80.24 %
Market Cap. Revenues TTM Net Income TTM

$ 3.182 mill.


$ 2.516 mill.


$ -10.067 mill.

Employees Shares Outstanding P/E

-


2 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 80.24 %


MRQ Y/Y - %



MOTS

$0.06

$-8.6640 -99.31%
Last 12 Months


MOTS

$0.06

$-8.6640 -99.31%



Motus Gi Holdings Inc

Motus Gi Holdings Inc stock declined -99.31% over the past 12 months.


Motus Gi Holdings Inc operates as a medical technology company that designs, develops, and commercializes innovative solutions for gastrointestinal endoscopy procedures. Their business model is centered around providing healthcare professionals with advanced imaging and therapeutic technologies to improve patient outcomes and enhance procedural efficiency.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.517 mill. $ -441.767 mill. $ -1.891 mill. 9 mill. - Y/Y -41.28 %
Market Cap. Revenues TTM Net Income TTM

$ 0.517 mill.


$ -441.767 mill.


$ -1.891 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -41.28 %


MRQ Y/Y - %



SINT

$5.1

$-328.9000 -98.47%
Last 12 Months


SINT

$5.1

$-328.9000 -98.47%



Sintx Technologies Inc

Sintx Technologies Inc shares went down -98.47% over the past 12 months.


Sintx Technologies Inc is a company that operates under a business model focused on developing and commercializing silicon nitride-based ceramics for various applications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.879 mill. $ 2.775 mill. $ -8.852 mill. 0 mill. - Y/Y 27.46 %
Market Cap. Revenues TTM Net Income TTM

$ 0.879 mill.


$ 2.775 mill.


$ -8.852 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 27.46 %


MRQ Y/Y - %



NMRD

$0.0321

$-0.9144 -96.61%
Last 12 Months


NMRD

$0.0321

$-0.9144 -96.61%



Nemaura Medical Inc

Nemaura Medical Inc stock declined -96.61% over the past 12 months.


Nemaura Medical Inc*s business model revolves around developing innovative and cost-effective medical technologies and devices.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ - mill. $ -10.651 mill. - mill. 0.08 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ - mill.


$ - mill.


$ -10.651 mill.

Employees Shares Outstanding P/E

-


- mill.


0.08

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



AFIB

$0.031

$-0.7570 -96.07%
Last 12 Months


AFIB

$0.031

$-0.7570 -96.07%



Acutus Medical Inc

Acutus Medical Inc shares declined -96.07% over the past 12 months.


Acutus Medical Inc is a medical technology company that develops and commercializes products for the diagnosis and treatment of cardiac arrhythmias. Their business model focuses on producing innovative and advanced medical devices, such as 3D imaging and mapping systems, to help physicians accurately identify and treat irregular heart rhythms.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.921 mill. $ 47.447 mill. $ -66.968 mill. 30 mill. - Y/Y -28.78 %
Market Cap. Revenues TTM Net Income TTM

$ 0.921 mill.


$ 47.447 mill.


$ -66.968 mill.

Employees Shares Outstanding P/E

-


30 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -28.78 %


MRQ Y/Y - %



HSCS

$3.64

$-86.3600 -95.96%
Last 12 Months


HSCS

$3.64

$-86.3600 -95.96%



Heart Test Laboratories Inc

Heart Test Laboratories Inc shares dropped -95.96% over the past 12 months.


Heart Test Laboratories Inc operates as a medical diagnostic company that specializes in heart testing. Their business model revolves around providing innovative and accurate cardiovascular diagnostic tests to healthcare facilities and patients, aimed at early detection and prevention of heart diseases. They achieve this by leveraging advanced technology, collaborating with medical professionals, and offering their services through partnerships with hospitals, clinics, and physicians.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.398 mill. $ 0.006 mill. $ -6.090 mill. 0 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.398 mill.


$ 0.006 mill.


$ -6.090 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NUWE

$3.8

$-77.7010 -95.34%
Last 12 Months


NUWE

$3.8

$-77.7010 -95.34%



Nuwellis Inc

Nuwellis Inc shares declined -95.34% over the past 12 months.


Nuwellis Inc.*s business model revolves around developing and commercializing innovative therapeutic solutions, predominantly focusing on fluid management to improve outcomes for patients with critical illnesses. They aim to provide advanced medical devices and solutions to healthcare professionals, addressing the pressing need for better fluid management in critical care settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.683 mill. $ 8.014 mill. $ -17.093 mill. 0 mill. - Y/Y 1.70 %
Market Cap. Revenues TTM Net Income TTM

$ 0.683 mill.


$ 8.014 mill.


$ -17.093 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 1.70 %


MRQ Y/Y - %



SONX

$0.0723

$-1.2677 -94.60%
Last 12 Months


SONX

$0.0723

$-1.2677 -94.60%



Sonendo Inc

Sonendo Inc stock declined -94.60% over the past 12 months.


Sonendo Inc*s business model revolves around providing innovative solutions for root canal therapy.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.817 mill. $ 42.498 mill. $ -60.893 mill. 94 mill. - Y/Y -4.06 %
Market Cap. Revenues TTM Net Income TTM

$ 6.817 mill.


$ 42.498 mill.


$ -60.893 mill.

Employees Shares Outstanding P/E

-


94 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -4.06 %


MRQ Y/Y - %



NDRA

$0.0761

$-1.3039 -94.49%
Last 12 Months


NDRA

$0.0761

$-1.3039 -94.49%



Endra Life Sciences Inc

Endra Life Sciences Inc stock dropped -94.49% over the past 12 months.


Endra Life Sciences Inc*s business model focuses on developing and commercializing advanced imaging technologies and solutions for medical and industrial applications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.822 mill. $ - mill. $ -9.893 mill. 11 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.822 mill.


$ - mill.


$ -9.893 mill.

Employees Shares Outstanding P/E

-


11 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



HSDT

$0.85

$-8.6550 -91.06%
Last 12 Months


HSDT

$0.85

$-8.6550 -91.06%



Helius Medical Technologies inc

Helius Medical Technologies Inc shares dropped -91.06% over the past 12 months.


Helius Medical Technologies Inc is a company that operates on a subscription-based business model, providing medical technology solutions for the treatment of neurological symptoms and conditions through its proprietary platform known as PoNS. This includes offering PoNS devices and related therapy services to healthcare providers and patients, with an aim to improve patient outcomes and quality of life.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.695 mill. $ 0.668 mill. $ -8.872 mill. 1 mill. - Y/Y 21.62 %
Market Cap. Revenues TTM Net Income TTM

$ 0.695 mill.


$ 0.668 mill.


$ -8.872 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 21.62 %


MRQ Y/Y - %



LYRA

$0.28

$-2.7900 -90.88%
Last 12 Months


LYRA

$0.28

$-2.7900 -90.88%



Lyra Therapeutics Inc

Lyra Therapeutics Inc stock declined -90.88% over the past 12 months.


Lyra Therapeutics Inc is a biotechnology company that focuses on developing drug-delivery systems for patients with ear, nose, and throat (ENT) diseases. They utilize their proprietary technology, known as XTreo, to precisely deliver therapeutics to targeted areas within the ENT region. Their business model revolves around developing and commercializing these unique drug-delivery solutions to address unmet medical needs in the ENT field.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 15.947 mill. $ 1.423 mill. $ -61.759 mill. 57 mill. - Y/Y 51.53 %
Market Cap. Revenues TTM Net Income TTM

$ 15.947 mill.


$ 1.423 mill.


$ -61.759 mill.

Employees Shares Outstanding P/E

-


57 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 51.53 %


MRQ Y/Y - %



ENDV

$0.0012

$-0.0115 -90.55%
Last 12 Months


ENDV

$0.0012

$-0.0115 -90.55%



Endonovo Therapeutics Inc

Endonovo Therapeutics Inc stock went down -90.55% over the past 12 months.


Endonovo Therapeutics Inc is a biotechnology company focused on the development of non-invasive electroceuticals for regenerative therapies. Their business model centers around the research, development, and commercialization of their innovative technology that stimulates the body*s natural healing process. With a focus on treating inflammatory conditions and diseases, Endonovo aims to provide advanced, non-pharmaceutical solutions for improved patient outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.621 mill. $ 0.256 mill. $ -4.404 mill. 1,351 mill. - Y/Y -86.13 %
Market Cap. Revenues TTM Net Income TTM

$ 1.621 mill.


$ 0.256 mill.


$ -4.404 mill.

Employees Shares Outstanding P/E

-


1,351 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -86.13 %


MRQ Y/Y - %



CUTR

$1.59

$-14.5400 -90.14%
Last 12 Months


CUTR

$1.59

$-14.5400 -90.14%



Cutera Inc

Cutera Inc stock went down -90.14% over the past 12 months.


Cutera Inc is a medical device company that specializes in aesthetic and medical laser technologies. Their business model revolves around developing and manufacturing innovative laser systems for various medical applications including hair removal, skin rejuvenation, and vascular therapies. By selling these advanced devices to physicians, medical spas, and clinics, Cutera aims to provide effective solutions for a wide range of aesthetic and medical conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 31.786 mill. $ 196.281 mill. $ -157.563 mill. 20 mill. - Y/Y -28.37 %
Market Cap. Revenues TTM Net Income TTM

$ 31.786 mill.


$ 196.281 mill.


$ -157.563 mill.

Employees Shares Outstanding P/E

402


20 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -28.37 %


MRQ Y/Y - %



BBLG

$1.11

$-9.4100 -89.45%
Last 12 Months


BBLG

$1.11

$-9.4100 -89.45%



Bone Biologics Corporation

Bone Biologics Corporation shares dropped -89.45% over the past 12 months.


Bone Biologics Corporation is a biotech company that focuses on the development and commercialization of innovative orthobiologic products to enhance bone healing. Their business model revolves around conducting research, developing proprietary technologies, and partnering with medical device companies to bring their products to market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.734 mill. $ - mill. $ -7.233 mill. 1 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.734 mill.


$ - mill.


$ -7.233 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



AVGR

$1.76

$-13.9900 -88.83%
Last 12 Months


AVGR

$1.76

$-13.9900 -88.83%



Avinger Inc

Avinger Inc stock dropped -88.83% over the past 12 months.


Avinger Inc is a medical technology company that operates with a business model focused on developing and commercializing innovative treatments for peripheral artery disease. Their business revolves around providing advanced devices and imaging systems that enable physicians to precisely navigate and treat patients* arteries, reducing the risk of complications and improving patient outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.600 mill. $ 6.458 mill. $ -17.350 mill. 1 mill. - Y/Y -28.87 %
Market Cap. Revenues TTM Net Income TTM

$ 2.600 mill.


$ 6.458 mill.


$ -17.350 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -28.87 %


MRQ Y/Y - %



RBOT

$7.85

$-51.5500 -86.78%
Last 12 Months


RBOT

$7.85

$-51.5500 -86.78%



Vicarious Surgical Inc

Vicarious Surgical Inc shares went down -86.78% over the past 12 months.


Vicarious Surgical Inc utilizes a business model that combines robotics and virtual reality to revolutionize surgical procedures. Their technology allows surgeons to perform minimally invasive surgeries with precision and control using robotic arms guided by a virtual reality interface. By offering an innovative solution to traditional surgical methods, Vicarious Surgical aims to enhance patient outcomes while minimizing the invasiveness and risks associated with traditional procedures.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 41.092 mill. $ - mill. $ -69.140 mill. 5 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 41.092 mill.


$ - mill.


$ -69.140 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



XAIR

$0.5677

$-3.5123 -86.09%
Last 12 Months


XAIR

$0.5677

$-3.5123 -86.09%



Beyond Air Inc

Beyond Air Inc stock dropped -86.09% over the past 12 months.


Beyond Air Inc is a company that operates on a business model focused on developing and commercializing medical devices for the treatment of respiratory conditions using innovative nitric oxide technology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 18.791 mill. $ 4.533 mill. $ -64.295 mill. 33 mill. - Y/Y 423.63 %
Market Cap. Revenues TTM Net Income TTM

$ 18.791 mill.


$ 4.533 mill.


$ -64.295 mill.

Employees Shares Outstanding P/E

-


33 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 423.63 %


MRQ Y/Y - %



RSLS

$0.2114

$-1.2286 -85.32%
Last 12 Months


RSLS

$0.2114

$-1.2286 -85.32%



Reshape Lifesciences Inc

Reshape Lifesciences Inc shares went down -85.32% over the past 12 months.


Reshape Lifesciences Inc*s business model revolves around developing and commercializing innovative medical devices to treat obesity and metabolic diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.959 mill. $ 8.205 mill. $ -10.918 mill. 23 mill. - Y/Y -15.00 %
Market Cap. Revenues TTM Net Income TTM

$ 4.959 mill.


$ 8.205 mill.


$ -10.918 mill.

Employees Shares Outstanding P/E

-


23 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -15.00 %


MRQ Y/Y - %



POAI

$1.09

$-5.0600 -82.28%
Last 12 Months


POAI

$1.09

$-5.0600 -82.28%



Predictive Oncology Inc

Predictive Oncology Inc shares went down -82.28% over the past 12 months.


Predictive Oncology Inc is a company that utilizes artificial intelligence to develop predictive models for cancer therapy outcomes. They collaborate with physicians and healthcare providers to apply their models in the clinical setting, aiding in personalized treatment decisions. Their business model revolves around leveraging data analytics and AI technology to offer tailored solutions for the field of oncology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.429 mill. $ 1.960 mill. $ -14.781 mill. 4 mill. - Y/Y 74.93 %
Market Cap. Revenues TTM Net Income TTM

$ 4.429 mill.


$ 1.960 mill.


$ -14.781 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 74.93 %


MRQ Y/Y - %



IONM

$3.1

$-12.8300 -80.54%
Last 12 Months


IONM

$3.1

$-12.8300 -80.54%



Assure Holdings Corp

Assure Holdings Corp shares declined -80.54% over the past 12 months.


Assure Holdings Corp is a healthcare company focused on providing neurophysiologic testing services to surgeons and healthcare facilities. They specialize in intraoperative neuromonitoring (IONM) and ensure real-time monitoring and assessment of the nervous system during surgeries. Their business model revolves around offering these specialized services to enhance patient safety and surgical outcomes while working closely with surgeons and hospitals.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.206 mill. $ - mill. $ -25.525 mill. 0 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.206 mill.


$ - mill.


$ -25.525 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



LGMK

$0.5837

$-2.3163 -79.87%
Last 12 Months


LGMK

$0.5837

$-2.3163 -79.87%



Logicmark Inc

Logicmark Inc shares declined -79.87% over the past 12 months.


Logicmark Inc*s business model revolves around designing, manufacturing, and marketing personal emergency response systems (PERS) and related technology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.806 mill. $ 9.650 mill. $ -7.982 mill. 1 mill. - Y/Y -13.97 %
Market Cap. Revenues TTM Net Income TTM

$ 0.806 mill.


$ 9.650 mill.


$ -7.982 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -13.97 %


MRQ Y/Y - %



OM

$3.87

$-15.1650 -79.67%
Last 12 Months


OM

$3.87

$-15.1650 -79.67%



Outset Medical Inc

Outset Medical Inc shares dropped -79.67% over the past 12 months.


Outset Medical Inc*s business model revolves around the production and distribution of innovative medical devices for kidney dialysis. With a focus on patient-centric care, their flagship product Tablo simplifies dialysis and allows for it to be performed in various clinical settings, including hospitals, clinics, and homes. By offering a comprehensive solution that combines hardware, software, and support services, Outset Medical aims to improve the dialysis experience for both healthcare providers and patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 192.168 mill. $ 131.334 mill. $ -175.641 mill. 50 mill. - Y/Y 8.63 %
Market Cap. Revenues TTM Net Income TTM

$ 192.168 mill.


$ 131.334 mill.


$ -175.641 mill.

Employees Shares Outstanding P/E

500


50 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 8.63 %


MRQ Y/Y - %



SKIN

$1.79

$-6.1400 -77.43%
Last 12 Months


SKIN

$1.79

$-6.1400 -77.43%



The Beauty Health Company

The Beauty Health Company stock declined -77.43% over the past 12 months.


The Beauty Health Company*s business model revolves around selling beauty and health products directly to consumers through a multi-level marketing strategy. Independent distributors are recruited and trained to promote and sell the company*s products to their network, earning commissions and bonuses based on their sales and the sales of their downline. The company focuses on building a loyal customer base while offering opportunities for individuals to earn income through selling and building their own sales teams.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 258.614 mill. $ 392.196 mill. $ -78.510 mill. 144 mill. - Y/Y -5.70 %
Market Cap. Revenues TTM Net Income TTM

$ 258.614 mill.


$ 392.196 mill.


$ -78.510 mill.

Employees Shares Outstanding P/E

-


144 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -5.70 %


MRQ Y/Y - %



PIII

$0.5524

$-1.8476 -76.98%
Last 12 Months


PIII

$0.5524

$-1.8476 -76.98%



P3 Health Partners Inc

P3 Health Partners Inc stock dropped -76.98% over the past 12 months.


P3 Health Partners Inc operates on a value-based care model, aiming to provide comprehensive, coordinated, and proactive healthcare services to patients. They focus on delivering personalized care through an interdisciplinary team including primary care physicians, specialists, care coordinators, and behavioral health professionals. P3 Health Partners Inc also aims to reduce healthcare costs by improving patient outcomes and preventing hospital readmissions through their collaborative and patient-centered approach.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 65.673 mill. $ 1,352.786 mill. $ -183.584 mill. 119 mill. - Y/Y 28.61 %
Market Cap. Revenues TTM Net Income TTM

$ 65.673 mill.


$ 1,352.786 mill.


$ -183.584 mill.

Employees Shares Outstanding P/E

1,600


119 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 28.61 %


MRQ Y/Y - %



APYX

$1.35

$-4.5100 -76.96%
Last 12 Months


APYX

$1.35

$-4.5100 -76.96%



Apyx Medical Corporation

Apyx Medical Corporation stock dropped -76.96% over the past 12 months.


Apyx Medical Corporation follows a business model that centers around the development, manufacturing, and marketing of medical devices used in the field of aesthetics and surgical markets. The company focuses on creating innovative products that improve patient outcomes and enhance the effectiveness of surgical procedures. Apyx Medical Corporation sells its devices primarily through a direct sales force in the United States, while utilizing a combination of direct sales representatives and distributors in international markets.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 46.489 mill. $ 49.566 mill. $ -22.908 mill. 34 mill. - Y/Y -18.06 %
Market Cap. Revenues TTM Net Income TTM

$ 46.489 mill.


$ 49.566 mill.


$ -22.908 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -18.06 %


MRQ Y/Y - %



NAOV

$0.78

$-2.5000 -76.22%
Last 12 Months


NAOV

$0.78

$-2.5000 -76.22%



Nanovibronix Inc

Nanovibronix Inc stock declined -76.22% over the past 12 months.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.958 mill. $ 2.027 mill. $ -3.486 mill. 3 mill. - Y/Y 849.48 %
Market Cap. Revenues TTM Net Income TTM

$ 1.958 mill.


$ 2.027 mill.


$ -3.486 mill.

Employees Shares Outstanding P/E

-


3 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 849.48 %


MRQ Y/Y - %



STSS

$0.21

$-0.6659 -76.02%
Last 12 Months


STSS

$0.21

$-0.6659 -76.02%



Sharps Technology Inc

Sharps Technology Inc stock declined -76.02% over the past 12 months.


Sharps Technology Inc operates as a technology solutions provider, offering a range of products and services to businesses in various industries. Their business model is focused on developing and delivering innovative technological solutions tailored to meet their clients* specific needs and requirements. By leveraging their expertise, they aim to help businesses enhance efficiency, productivity, and overall performance through the implementation of cutting-edge technological solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.918 mill. $ - mill. $ 5.527 mill. 19 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 3.918 mill.


$ - mill.


$ 5.527 mill.

Employees Shares Outstanding P/E

-


19 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



DYNT

$0.2202

$-0.6397 -74.39%
Last 12 Months


DYNT

$0.2202

$-0.6397 -74.39%



Dynatronics Corporation

Dynatronics Corporation shares declined -74.39% over the past 12 months.


Dynatronics Corporation*s business model revolves around developing, manufacturing, and distributing medical devices with a focus on rehabilitation and physical therapy.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.996 mill. $ 35.743 mill. $ -4.726 mill. 5 mill. - Y/Y -32.37 %
Market Cap. Revenues TTM Net Income TTM

$ 0.996 mill.


$ 35.743 mill.


$ -4.726 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -32.37 %


MRQ Y/Y - %



BTCY

$0.824

$-2.1760 -72.53%
Last 12 Months


BTCY

$0.824

$-2.1760 -72.53%



Biotricity Inc

Biotricity Inc stock dropped -72.53% over the past 12 months.


The business model of Biotricity Inc focuses on providing medical technology solutions through the development and commercialization of innovative biomedical devices and services. The company leverages its expertise in remote patient monitoring, data analytics, and artificial intelligence to deliver personalized healthcare solutions to both patients and healthcare professionals. Biotricity Inc aims to improve patient outcomes, reduce healthcare costs, and enhance the overall efficiency of the healthcare system.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.411 mill. $ 11.640 mill. $ -14.249 mill. 9 mill. - Y/Y 22.29 %
Market Cap. Revenues TTM Net Income TTM

$ 7.411 mill.


$ 11.640 mill.


$ -14.249 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 22.29 %


MRQ Y/Y - %



VERO

$0.59

$-1.4901 -71.64%
Last 12 Months


VERO

$0.59

$-1.4901 -71.64%



Venus Concept Inc

Venus Concept Inc shares dropped -71.64% over the past 12 months.


Venus Concept Inc*s business model focuses on offering innovative and effective medical aesthetic devices and technology solutions to healthcare professionals.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.439 mill. $ 55.607 mill. $ -37.216 mill. 6 mill. - Y/Y -16.83 %
Market Cap. Revenues TTM Net Income TTM

$ 3.439 mill.


$ 55.607 mill.


$ -37.216 mill.

Employees Shares Outstanding P/E

201


6 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -16.83 %


MRQ Y/Y - %



CTSO

$1.05

$-2.5800 -71.07%
Last 12 Months


CTSO

$1.05

$-2.5800 -71.07%



Cytosorbents Corporation

Cytosorbents Corporation stock went down -71.07% over the past 12 months.


Cytosorbents Corporation operates on a business model that focuses on the development and commercialization of novel products for blood purification. The company manufactures and sells its flagship product, CytoSorb, which is a blood purification technology designed to reduce cytokine storm in critically ill patients. Cytosorbents generates revenue by selling CytoSorb to hospitals, clinics, and healthcare providers globally.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 56.976 mill. $ 35.513 mill. $ -27.539 mill. 54 mill. - Y/Y 1.28 %
Market Cap. Revenues TTM Net Income TTM

$ 56.976 mill.


$ 35.513 mill.


$ -27.539 mill.

Employees Shares Outstanding P/E

-


54 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 1.28 %


MRQ Y/Y - %



PETV

$0.6199

$-1.5201 -71.03%
Last 12 Months


PETV

$0.6199

$-1.5201 -71.03%



Petvivo Holdings Inc

Petvivo Holdings Inc stock declined -71.03% over the past 12 months.


PetVivo Holdings Inc*s business model revolves around developing and commercializing innovative medical devices that benefit pets.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8.707 mill. $ 0.969 mill. $ -10.955 mill. 14 mill. - Y/Y -61.57 %
Market Cap. Revenues TTM Net Income TTM

$ 8.707 mill.


$ 0.969 mill.


$ -10.955 mill.

Employees Shares Outstanding P/E

4


14 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -61.57 %


MRQ Y/Y - %



DRIO

$1.2

$-2.9300 -70.94%
Last 12 Months


DRIO

$1.2

$-2.9300 -70.94%



Dariohealth Corp

Dariohealth Corp stock went down -70.94% over the past 12 months.


DarioHealth Corp*s business model revolves around providing digital health solutions to individuals with chronic diseases. Through their mobile health platform, they offer personalized tools and remote monitoring capabilities that empower patients to proactively manage their conditions. By combining software, data analytics, and medical devices, DarioHealth aims to enhance patient engagement, improve health outcomes, and reduce healthcare costs.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 41.331 mill. $ 18.350 mill. $ 53.777 mill. 34 mill. 0.71 Y/Y -23.12 %
Market Cap. Revenues TTM Net Income TTM

$ 41.331 mill.


$ 18.350 mill.


$ 53.777 mill.

Employees Shares Outstanding P/E

-


34 mill.


0.71

Revenue Growth Income Growth

MRQ Y/Y -23.12 %


MRQ Y/Y -44.05 %



BJDX

$0.6268

$-1.4532 -69.87%
Last 12 Months


BJDX

$0.6268

$-1.4532 -69.87%



Bluejay Diagnostics Inc

Bluejay Diagnostics Inc stock went down -69.87% over the past 12 months.


Bluejay Diagnostics Inc follows a business model where they develop and manufacture diagnostic tests and medical devices for a variety of health conditions, aiming to provide accurate and efficient solutions to healthcare professionals and patients. They primarily operate by selling their products to hospitals, clinics, and other medical institutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.086 mill. $ - mill. $ -10.037 mill. 0 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.086 mill.


$ - mill.


$ -10.037 mill.

Employees Shares Outstanding P/E

-


0 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MOVE

$0.4186

$-0.9414 -69.22%
Last 12 Months


MOVE

$0.4186

$-0.9414 -69.22%



Movano Inc

Movano Inc stock dropped -69.22% over the past 12 months.


a Delaware corporation, is developing a platform to deliver purpose-driven healthcare solutions at the intersection of medtech and consumer devices


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 21.228 mill. $ - mill. $ -31.252 mill. 51 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 21.228 mill.


$ - mill.


$ -31.252 mill.

Employees Shares Outstanding P/E

27


51 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



ATAO

$0.0265

$-0.0584 -68.79%
Last 12 Months


ATAO

$0.0265

$-0.0584 -68.79%



Altair International Corp

Altair International Corp stock dropped -68.79% over the past 12 months.


Altair International Corp is a diversified company with a business model focused on providing a range of products and services. Their offerings span various sectors, including technology, finance, health, and real estate. By leveraging their expertise and network, Altair International Corp aims to capitalize on opportunities and generate revenue through strategic investments, partnerships, and market expansion.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.529 mill. $ - mill. $ -0.399 mill. 20 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 0.529 mill.


$ - mill.


$ -0.399 mill.

Employees Shares Outstanding P/E

-


20 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



BSGM

$0.4385

$-0.9515 -68.45%
Last 12 Months


BSGM

$0.4385

$-0.9515 -68.45%



Biosig Technologies Inc

Biosig Technologies Inc shares declined -68.45% over the past 12 months.


Biosig Technologies Inc is a medical device company that specializes in innovative solutions for the healthcare industry. Their business model revolves around developing and commercializing proprietary technologies, particularly in the field of physiological signal monitoring. By creating and marketing advanced medical devices, Biosig aims to improve patient outcomes and provide healthcare professionals with valuable tools for better diagnostics and treatment.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.322 mill. $ -272.981 mill. $ -4.843 mill. 10 mill. 0.23 Y/Y -89.63 %
Market Cap. Revenues TTM Net Income TTM

$ 4.322 mill.


$ -272.981 mill.


$ -4.843 mill.

Employees Shares Outstanding P/E

-


10 mill.


0.23

Revenue Growth Income Growth

MRQ Y/Y -89.63 %


MRQ Y/Y - %



PYPD

$3.43

$-7.0730 -67.34%
Last 12 Months


PYPD

$3.43

$-7.0730 -67.34%



Polypid Ltd

Polypid Ltd stock declined -67.34% over the past 12 months.


Polypid Ltd is a pharmaceutical company that operates on a product-based business model. They develop and offer innovative drug delivery solutions for various medical applications. Their focus is on creating long-acting therapies that improve patient outcomes and simplify treatment regimens, ultimately empowering healthcare providers with effective solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.221 mill. $ - mill. $ 39.557 mill. 1 mill. 0.06 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 2.221 mill.


$ - mill.


$ 39.557 mill.

Employees Shares Outstanding P/E

-


1 mill.


0.06

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y -7.15 %



TMCI

$7.88

$-15.8900 -66.85%
Last 12 Months


TMCI

$7.88

$-15.8900 -66.85%



Treace Medical Concepts Inc

Treace Medical Concepts Inc shares dropped -66.85% over the past 12 months.


Treace Medical Concepts Inc offers innovative surgical solutions primarily for foot and ankle disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 485.112 mill. $ 153.618 mill. $ -62.723 mill. 62 mill. - Y/Y 23.30 %
Market Cap. Revenues TTM Net Income TTM

$ 485.112 mill.


$ 153.618 mill.


$ -62.723 mill.

Employees Shares Outstanding P/E

-


62 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 23.30 %


MRQ Y/Y - %



LUCY

$5.52

$-10.5920 -65.74%
Last 12 Months


LUCY

$5.52

$-10.5920 -65.74%



Innovative Eyewear Inc

Innovative Eyewear Inc shares dropped -65.74% over the past 12 months.


Innovative Eyewear Inc*s business model focuses on creating and selling innovative eyewear products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 71.496 mill. $ 1.391 mill. $ -7.204 mill. 13 mill. - Y/Y 164.61 %
Market Cap. Revenues TTM Net Income TTM

$ 71.496 mill.


$ 1.391 mill.


$ -7.204 mill.

Employees Shares Outstanding P/E

-


13 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 164.61 %


MRQ Y/Y - %




 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com